Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to -$679968.0.

  • cbdMD's Net Income towards Common Stockholders rose 4114.35% to -$679968.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year increase of 4320.7%. This contributed to the annual value of -$4.4 million for FY2025, which is 4320.7% up from last year.
  • As of Q3 2025, cbdMD's Net Income towards Common Stockholders stood at -$679968.0, which was up 4114.35% from -$1.2 million recorded in Q2 2025.
  • cbdMD's Net Income towards Common Stockholders' 5-year high stood at $977007.0 during Q2 2021, with a 5-year trough of -$32.6 million in Q2 2022.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$2.8 million (2023), whereas its average is -$6.8 million.
  • As far as peak fluctuations go, cbdMD's Net Income towards Common Stockholders skyrocketed by 11079.24% in 2021, and later tumbled by 344026.72% in 2022.
  • Over the past 5 years, cbdMD's Net Income towards Common Stockholders (Quarter) stood at -$20.2 million in 2021, then surged by 75.42% to -$5.0 million in 2022, then surged by 59.71% to -$2.0 million in 2023, then surged by 50.66% to -$985406.0 in 2024, then soared by 31.0% to -$679968.0 in 2025.
  • Its Net Income towards Common Stockholders was -$679968.0 in Q3 2025, compared to -$1.2 million in Q2 2025 and -$1.5 million in Q1 2025.